Overview

Eltrombopag for Post Transplant Thrombocytopenia

Status:
Completed

Trial end date:
2018-04-04

Target enrollment:

Participant gender:

Summary

The goal of this clinical research study is to learn if eltrombopag can help to improve platelet counts in patients with low platelets after they have had a stem cell transplant. The safety of this drug will also be studied.

Phase:

Phase 2

Details

Lead Sponsor:

M.D. Anderson Cancer Center

Collaborator:

Novartis Pharmaceuticals